Self-administered HPV tests could improve cervical cancer screening
HQ Team December 18, 2024: Self-administered test for human papillomavirus, HPV, can help women self screen for risk of cervical cancer, according to
Health
Drugs
Pharma
Russia announces free cancer vaccine for citizens by 2025
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free
Pharma
Research
Clinical trial of AEF0217 for cognitive function in Down Syndrome shows promise
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial
Climate
Research
Decline in Arctic ice impacting polar bear habitat and gut health
HQ Team December 17, 2024: In a study conducted in Churchill, Manitoba—often dubbed the “Polar Bear Capital of the World”—researchers from Dalhousie University
Climate
Health
Medical
Only seven countries meet safe air quality levels
HQ Team December 16, 2024: The 2023 World Air Quality Report, released by Swiss air quality technology company IQAir, revealed that only seven
Uncategorized
Elevated β-hCG linked to BRCA1 mutations in breast cancer
Bharti Jayshankar December 16, 2024: Researchers at the Rajiv Gandhi Biotechnology Centre, Kerala, delving into the molecular mechanisms of tumorigenesis by BRCA1 gene,
Drugs
Pharma
ICER report highlights unsupported price increases of prescription drugs
HQ Team December 13, 2024: The Institute for Clinical and Economic Review (ICER) has released a new report revealing that five high-expenditure drugs
Drugs
Pharma
AstraZeneca, Merck announce promising results for breast cancer in trial 3
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly
Drugs
Pharma
Breakthrough in halting dementia progression found by biotech company
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,